I have been saying that for awhile. I cannot provide you with any numbers, but I know the cost savings from GTCBs platform is not what it once was. Where once I believed there was the opportunity to shock the world, my take now is that GTCB will develop into a nice little company, and maybe go from there.
You are making the erronious assumption that the only difference between transgenic production by GTCB and cell cultures is the amount of protein produced.